{"ncbi_accession":["SRR16168895"],"spots":9813517,"bases":2926272161,"biosample":"SAMN21886459","sra_experiment":"SRX12453754","sra_sample":"SRS10419794","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886459","subject_id":"PD1TPF18137dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":78,"age_category":"senior","gender":"male","bmi":22.96,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":19627034,"number_bases":2926272161,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"nivolumab","recist":"PD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168940"],"spots":39639231,"bases":11825748242,"biosample":"SAMN21886418","sra_experiment":"SRX12453709","sra_sample":"SRS10419749","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886418","subject_id":"PD1SS17063dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":77,"age_category":"senior","gender":"male","bmi":18.92,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":79278462,"number_bases":11825748242,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"nivolumab;antacids;H2RA;psychotropics","recist":"PD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168896"],"spots":45234488,"bases":13431960637,"biosample":"SAMN21886458","sra_experiment":"SRX12453753","sra_sample":"SRS10419793","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886458","subject_id":"PD1TPF1865dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":60,"age_category":"adult","gender":"male","bmi":33.94,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":90468976,"number_bases":13431960637,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"nivolumab;antacids;PPI;H2RA","recist":"PD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168907"],"spots":46204468,"bases":13725560396,"biosample":"SAMN21886448","sra_experiment":"SRX12453742","sra_sample":"SRS10419783","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886448","subject_id":"PD1TPF18186dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":66,"age_category":"senior","gender":"female","bmi":18.42,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":92408936,"number_bases":13725560396,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"nivolumab;antacids;PPI;H2RA;psychotropics","recist":"SD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168897"],"spots":10188473,"bases":3028505656,"biosample":"SAMN21886457","sra_experiment":"SRX12453752","sra_sample":"SRS10419792","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886457","subject_id":"PD1TPF18175dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"yes","study_condition":"melanoma","disease":"melanoma","age":79,"age_category":"senior","gender":"male","bmi":20.31,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":20376946,"number_bases":3028505656,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"nivolumab;antacids;PPI;psychotropics","recist":"SD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168899"],"spots":12418539,"bases":3700981354,"biosample":"SAMN21886456","sra_experiment":"SRX12453750","sra_sample":"SRS10419790","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886456","subject_id":"PD1TPF18263dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":32,"age_category":"adult","gender":"female","bmi":33.1,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":24837078,"number_bases":3700981354,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"nivolumab;psychotropics","recist":"PR","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168919"],"spots":60926857,"bases":18208778490,"biosample":"SAMN21886437","sra_experiment":"SRX12453730","sra_sample":"SRS10419769","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886437","subject_id":"PD1TPF18228dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":73,"age_category":"senior","gender":"male","bmi":24.92,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":121853714,"number_bases":18208778490,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab","recist":"PD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168951"],"spots":30562124,"bases":9130751192,"biosample":"SAMN21886408","sra_experiment":"SRX12453698","sra_sample":"SRS10419738","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886408","subject_id":"PD1TPF17210dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":78,"age_category":"senior","gender":"female","bmi":27.21,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":61124248,"number_bases":9130751192,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-d","treatment":"pembrolizumab","recist":"SD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168976"],"spots":35357033,"bases":10523527203,"biosample":"SAMN21886386","sra_experiment":"SRX12453673","sra_sample":"SRS10419713","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886386","subject_id":"PD1SS17081dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":61,"age_category":"adult","gender":"male","bmi":28.41,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":70714066,"number_bases":10523527203,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab","recist":"PD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168939"],"spots":27277490,"bases":8155500740,"biosample":"SAMN21886419","sra_experiment":"SRX12453710","sra_sample":"SRS10419750","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886419","subject_id":"PD1SS17023dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":67,"age_category":"senior","gender":"male","bmi":28.49,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":54554980,"number_bases":8155500740,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab;antacids;PPI;H2RA;peg-IFN","recist":"SD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168923"],"spots":69176494,"bases":20619544740,"biosample":"SAMN21886434","sra_experiment":"SRX12453726","sra_sample":"SRS10419766","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886434","subject_id":"PD1TPF18193dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":83,"age_category":"senior","gender":"male","bmi":24.95,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":138352988,"number_bases":20619544740,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-d","treatment":"pembrolizumab;antacids;PPI;H2RA;psychotropics","recist":"SD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168917"],"spots":14072054,"bases":4188183543,"biosample":"SAMN21886439","sra_experiment":"SRX12453732","sra_sample":"SRS10419772","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886439","subject_id":"PD1TPF18130dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"yes","study_condition":"melanoma","disease":"melanoma","age":53,"age_category":"adult","gender":"female","bmi":18.03,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":28144108,"number_bases":4188183543,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab;methotrexate;psychotropics","recist":"PD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168982"],"spots":37332422,"bases":11157092108,"biosample":"SAMN21886380","sra_experiment":"SRX12453667","sra_sample":"SRS10419707","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886380","subject_id":"PD1SS17003dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":49,"age_category":"adult","gender":"male","bmi":37.36,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":74664844,"number_bases":11157092108,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab;peg-IFN","recist":"PD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168970"],"spots":42737748,"bases":12745350817,"biosample":"SAMN21886391","sra_experiment":"SRX12453679","sra_sample":"SRS10419719","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886391","subject_id":"PD1SS17072dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":70,"age_category":"senior","gender":"male","bmi":37.75,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":85475496,"number_bases":12745350817,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab;psychotropics","recist":"PR","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168912"],"spots":74238401,"bases":22134405414,"biosample":"SAMN21886444","sra_experiment":"SRX12453737","sra_sample":"SRS10419778","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886444","subject_id":"PD1TPF18131dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;adrenal_insufficiency","age":62,"age_category":"adult","gender":"male","bmi":39.3,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":148476802,"number_bases":22134405414,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"nivolumab;antacids;PPI;H2RA;psychotropics","recist":"PD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168950"],"spots":16822625,"bases":5029574567,"biosample":"SAMN21886409","sra_experiment":"SRX12453699","sra_sample":"SRS10419739","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886409","subject_id":"PD1TPF17258dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;arthritis","age":66,"age_category":"senior","gender":"male","bmi":32.44,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":33645250,"number_bases":5029574567,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-b","treatment":"pembrolizumab;antacids;PPI;H2RA;psychotropics","recist":"PD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168913"],"spots":70213494,"bases":20893356447,"biosample":"SAMN21886443","sra_experiment":"SRX12453736","sra_sample":"SRS10419776","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886443","subject_id":"PD1TPF1897dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;bullous_pemphigoid","age":66,"age_category":"senior","gender":"male","bmi":36.8,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":140426988,"number_bases":20893356447,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"nivolumab","recist":"PD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168904"],"spots":31629939,"bases":9434363033,"biosample":"SAMN21886451","sra_experiment":"SRX12453745","sra_sample":"SRS10419785","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886451","subject_id":"PD1TPF18280dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;bullous_pemphigoid","age":85,"age_category":"senior","gender":"male","bmi":34.28,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":63259878,"number_bases":9434363033,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab;antacids;PPI;H2RA;psychotropics","recist":"PD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168984"],"spots":30256747,"bases":9042937113,"biosample":"SAMN21886378","sra_experiment":"SRX12453665","sra_sample":"SRS10419705","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886378","subject_id":"PD128Pittsdna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;colitis","age":56,"age_category":"adult","gender":"male","bmi":31.31,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":60513494,"number_bases":9042937113,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab;peg-IFN;psychotropics","recist":"SD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168971"],"spots":26415583,"bases":7894806680,"biosample":"SAMN21886390","sra_experiment":"SRX12453678","sra_sample":"SRS10419718","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886390","subject_id":"PD117044dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;dermatitis","age":82,"age_category":"senior","gender":"male","bmi":26.16,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":52831166,"number_bases":7894806680,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab;psychotropics","recist":"CR","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168947"],"spots":24583975,"bases":7348602333,"biosample":"SAMN21886412","sra_experiment":"SRX12453702","sra_sample":"SRS10419742","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886412","subject_id":"PD1TPF17185dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hepatitis","age":77,"age_category":"senior","gender":"female","bmi":26.3,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":49167950,"number_bases":7348602333,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab;psychotropics","recist":"PD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168954"],"spots":32180866,"bases":9616070709,"biosample":"SAMN21886406","sra_experiment":"SRX12453695","sra_sample":"SRS10419735","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886406","subject_id":"PD1TPF17174dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hepatitis","age":65,"age_category":"senior","gender":"female","bmi":32.26,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":64361732,"number_bases":9616070709,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab;psychotropics","recist":"PD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168902"],"spots":23283278,"bases":6954942469,"biosample":"SAMN21886453","sra_experiment":"SRX12453747","sra_sample":"SRS10419788","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886453","subject_id":"PD1TPF1884dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hepatitis;dermatitis","age":66,"age_category":"senior","gender":"male","bmi":24.99,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":46566556,"number_bases":6954942469,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-d","treatment":"anti-PD1","recist":"PR","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168983"],"spots":20006723,"bases":5957414755,"biosample":"SAMN21886379","sra_experiment":"SRX12453666","sra_sample":"SRS10419706","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886379","subject_id":"PD116001dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hypothyroidism;dermatitis","age":84,"age_category":"senior","gender":"male","bmi":25.92,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":40013446,"number_bases":5957414755,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"nivolumab","recist":"SD","orr":"no","pfs12":"no","previous_therapy":"yes","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168900"],"spots":24218900,"bases":7219817191,"biosample":"SAMN21886455","sra_experiment":"SRX12453749","sra_sample":"SRS10419789","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886455","subject_id":"PD1TPF1871dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;myasthenia","age":80,"age_category":"senior","gender":"female","bmi":35.03,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":48437800,"number_bases":7219817191,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"nivolumab","recist":"PD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168941"],"spots":21319100,"bases":6361968462,"biosample":"SAMN21886417","sra_experiment":"SRX12453708","sra_sample":"SRS10419748","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886417","subject_id":"PD1SS17084dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;psoriasis","age":80,"age_category":"senior","gender":"male","bmi":39.82,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":42638200,"number_bases":6361968462,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab;antacids;PPI;H2RA","recist":"PD","orr":"no","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168901"],"spots":8038698,"bases":2397958627,"biosample":"SAMN21886454","sra_experiment":"SRX12453748","sra_sample":"SRS10419787","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886454","subject_id":"PD1TPF18191dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":77,"age_category":"senior","gender":"male","bmi":35.4,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":16077396,"number_bases":2397958627,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"anti-PD1","recist":"CR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168905"],"spots":4509085,"bases":1346496073,"biosample":"SAMN21886450","sra_experiment":"SRX12453744","sra_sample":"SRS10419784","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886450","subject_id":"PD1TPF18140dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":60,"age_category":"adult","gender":"male","bmi":41.57,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":9018170,"number_bases":1346496073,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"nivolumab","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168903"],"spots":11211637,"bases":3340301748,"biosample":"SAMN21886452","sra_experiment":"SRX12453746","sra_sample":"SRS10419786","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886452","subject_id":"PD1TPF18189dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":77,"age_category":"senior","gender":"male","bmi":27.86,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":22423274,"number_bases":3340301748,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"nivolumab;antacids;H2RA;PPI","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168894"],"spots":13307261,"bases":3964461728,"biosample":"SAMN21886460","sra_experiment":"SRX12453755","sra_sample":"SRS10419795","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886460","subject_id":"PD1TPF1835dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":64,"age_category":"adult","gender":"female","bmi":42.14,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":26614522,"number_bases":3964461728,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"nivolumab;psychotropics","recist":"CR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168920"],"spots":29534482,"bases":8827868987,"biosample":"SAMN21886374","sra_experiment":"SRX12453729","sra_sample":"SRS10419770","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886374","subject_id":"PD1TPF17183dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":41,"age_category":"adult","gender":"male","bmi":43.13,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":59068964,"number_bases":8827868987,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-b","treatment":"nivolumab;psychotropics","recist":"SD","orr":"yes","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168928"],"spots":45975755,"bases":13698254051,"biosample":"SAMN21886429","sra_experiment":"SRX12453721","sra_sample":"SRS10419761","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886429","subject_id":"PD1SS17010dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":74,"age_category":"senior","gender":"male","bmi":20.36,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":91951510,"number_bases":13698254051,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab","recist":"CR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168949"],"spots":36068834,"bases":10773282492,"biosample":"SAMN21886410","sra_experiment":"SRX12453700","sra_sample":"SRS10419740","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886410","subject_id":"PD117008dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":77,"age_category":"senior","gender":"female","bmi":23.79,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":72137668,"number_bases":10773282492,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-d","treatment":"pembrolizumab","recist":"CR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168958"],"spots":25864972,"bases":7719204791,"biosample":"SAMN21886402","sra_experiment":"SRX12453691","sra_sample":"SRS10419731","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886402","subject_id":"PD116008dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":66,"age_category":"senior","gender":"male","bmi":32.99,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":51729944,"number_bases":7719204791,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-b","treatment":"pembrolizumab","recist":"CR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168967"],"spots":37542713,"bases":11222487619,"biosample":"SAMN21886394","sra_experiment":"SRX12453682","sra_sample":"SRS10419722","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886394","subject_id":"PD1SS17067dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":75,"age_category":"senior","gender":"male","bmi":32.13,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":75085426,"number_bases":11222487619,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab","recist":"CR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168964"],"spots":11143484,"bases":3333573672,"biosample":"SAMN21886370","sra_experiment":"SRX12453685","sra_sample":"SRS10419725","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886370","subject_id":"PD1TPF1820dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":61,"age_category":"adult","gender":"male","bmi":28.34,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":22286968,"number_bases":3333573672,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab;antacids;H2RA;PPI","recist":"SD","orr":"yes","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168946"],"spots":24534408,"bases":7337744592,"biosample":"SAMN21886413","sra_experiment":"SRX12453703","sra_sample":"SRS10419743","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886413","subject_id":"PD116004dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":79,"age_category":"senior","gender":"male","bmi":22.61,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":49068816,"number_bases":7337744592,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab;antacids;PPI","recist":"CR","orr":"yes","pfs12":"yes","previous_therapy":"yes","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168921"],"spots":72979345,"bases":21710751544,"biosample":"SAMN21886436","sra_experiment":"SRX12453728","sra_sample":"SRS10419768","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886436","subject_id":"PD1TPF18195dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":68,"age_category":"senior","gender":"male","bmi":31.79,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":145958690,"number_bases":21710751544,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-d","treatment":"pembrolizumab;antacids;PPI;H2RA;psychotropics","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168915"],"spots":46763989,"bases":13924204124,"biosample":"SAMN21886441","sra_experiment":"SRX12453734","sra_sample":"SRS10419774","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886441","subject_id":"PD1TPF18111dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":66,"age_category":"senior","gender":"male","bmi":21.18,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":93527978,"number_bases":13924204124,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-d","treatment":"pembrolizumab;antacids;PPI;psychotropics","recist":"CR","orr":"yes","pfs12":"yes","previous_therapy":"yes","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168918"],"spots":72209592,"bases":21549187251,"biosample":"SAMN21886438","sra_experiment":"SRX12453731","sra_sample":"SRS10419771","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886438","subject_id":"PD1TPF1831dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"yes","study_condition":"melanoma","disease":"melanoma","age":85,"age_category":"senior","gender":"male","bmi":25.24,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":144419184,"number_bases":21549187251,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab;H2RA;PPI","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168929"],"spots":28682615,"bases":8560864604,"biosample":"SAMN21886428","sra_experiment":"SRX12453720","sra_sample":"SRS10419760","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886428","subject_id":"PD1SS17002dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":56,"age_category":"adult","gender":"male","bmi":23.24,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":57365230,"number_bases":8560864604,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab;peg-IFN","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168934"],"spots":18205354,"bases":5446300943,"biosample":"SAMN21886424","sra_experiment":"SRX12453715","sra_sample":"SRS10419755","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886424","subject_id":"PD123Pittsdna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":70,"age_category":"senior","gender":"male","bmi":31.39,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":36410708,"number_bases":5446300943,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-b","treatment":"pembrolizumab;peg-IFN","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"yes","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168962"],"spots":31065113,"bases":9287598630,"biosample":"SAMN21886398","sra_experiment":"SRX12453687","sra_sample":"SRS10419727","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886398","subject_id":"PD1SS17048dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":66,"age_category":"senior","gender":"male","bmi":26.43,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":62130226,"number_bases":9287598630,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab;peg-IFN","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168973"],"spots":24709505,"bases":7388240379,"biosample":"SAMN21886388","sra_experiment":"SRX12453676","sra_sample":"SRS10419716","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886388","subject_id":"PD1SS17075dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":83,"age_category":"senior","gender":"male","bmi":28.89,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":49419010,"number_bases":7388240379,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab;peg-IFN","recist":"SD","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168927"],"spots":14018704,"bases":4189652738,"biosample":"SAMN21886430","sra_experiment":"SRX12453722","sra_sample":"SRS10419762","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886430","subject_id":"PD126Pittsdna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":78,"age_category":"senior","gender":"male","bmi":26.94,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":28037408,"number_bases":4189652738,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-b","treatment":"pembrolizumab;peg-IFN;psychotropics","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168945"],"spots":32934888,"bases":9846636948,"biosample":"SAMN21886414","sra_experiment":"SRX12453704","sra_sample":"SRS10419744","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886414","subject_id":"PD117033dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":68,"age_category":"senior","gender":"male","bmi":28.41,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":65869776,"number_bases":9846636948,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-b","treatment":"pembrolizumab;peg-IFN;psychotropics","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168961"],"spots":34359166,"bases":10258044305,"biosample":"SAMN21886399","sra_experiment":"SRX12453688","sra_sample":"SRS10419728","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886399","subject_id":"PD1SS17083dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":41,"age_category":"adult","gender":"female","bmi":28.93,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":68718332,"number_bases":10258044305,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab;psychotropics","recist":"SD","orr":"yes","pfs12":"yes","previous_therapy":"yes","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168931"],"spots":38740101,"bases":11570892434,"biosample":"SAMN21886373","sra_experiment":"SRX12453718","sra_sample":"SRS10419758","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886373","subject_id":"PD1SS17021dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma","age":77,"age_category":"senior","gender":"female","bmi":28.9,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":77480202,"number_bases":11570892434,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab;psychotropics","recist":"SD","orr":"yes","pfs12":"yes","previous_therapy":"yes","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168969"],"spots":30080663,"bases":8973913129,"biosample":"SAMN21886392","sra_experiment":"SRX12453680","sra_sample":"SRS10419720","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886392","subject_id":"PD1SS17043dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;adrenal_insufficiency","age":77,"age_category":"senior","gender":"male","bmi":36.34,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":60161326,"number_bases":8973913129,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"nivolumab","recist":"SD","orr":"yes","pfs12":"yes","previous_therapy":"yes","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168922"],"spots":53515383,"bases":15957141770,"biosample":"SAMN21886435","sra_experiment":"SRX12453727","sra_sample":"SRS10419767","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886435","subject_id":"PD1TPF18176dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;adrenal_insufficiency","age":70,"age_category":"senior","gender":"male","bmi":22.52,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":107030766,"number_bases":15957141770,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab;antacids;PPI;H2RA","recist":"CR","orr":"yes","pfs12":"yes","previous_therapy":"yes","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168978"],"spots":27912283,"bases":8330700241,"biosample":"SAMN21886384","sra_experiment":"SRX12453671","sra_sample":"SRS10419711","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886384","subject_id":"PD116278dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;adrenal_insufficiency","age":76,"age_category":"senior","gender":"male","bmi":30.87,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":55824566,"number_bases":8330700241,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab;psychotropics","recist":"CR","orr":"yes","pfs12":"yes","previous_therapy":"yes","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168957"],"spots":13008215,"bases":3876955654,"biosample":"SAMN21886403","sra_experiment":"SRX12453692","sra_sample":"SRS10419732","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886403","subject_id":"PD1TPF17263dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;arthritis","age":48,"age_category":"adult","gender":"female","bmi":30.77,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":26016430,"number_bases":3876955654,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-b","treatment":"nivolumab;antacids;PPI;H2RA","recist":"CR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168933"],"spots":35488588,"bases":10600871075,"biosample":"SAMN21886425","sra_experiment":"SRX12453716","sra_sample":"SRS10419756","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886425","subject_id":"PD117040dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;bullous_pemphigoid","age":89,"age_category":"senior","gender":"male","bmi":27.86,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":70977176,"number_bases":10600871075,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-d","treatment":"pembrolizumab;antacids;PPI;H2RA;psychotropics","recist":"CR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168987"],"spots":24877824,"bases":7441719568,"biosample":"SAMN21886367","sra_experiment":"SRX12453662","sra_sample":"SRS10419702","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886367","subject_id":"PD1SS17052dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;colitis","age":36,"age_category":"adult","gender":"female","bmi":33.63,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":49755648,"number_bases":7441719568,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-b","treatment":"nivolumab","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168935"],"spots":20102967,"bases":6011981395,"biosample":"SAMN21886423","sra_experiment":"SRX12453714","sra_sample":"SRS10419754","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886423","subject_id":"PD117012dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;colitis","age":62,"age_category":"adult","gender":"male","bmi":35.98,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":40205934,"number_bases":6011981395,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-d","treatment":"nivolumab;psychotropics","recist":"CR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168911"],"spots":50507777,"bases":15070655060,"biosample":"SAMN21886445","sra_experiment":"SRX12453738","sra_sample":"SRS10419777","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886445","subject_id":"PD1TPF18203dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;colitis","age":50,"age_category":"adult","gender":"male","bmi":42.26,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":101015554,"number_bases":15070655060,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-b","treatment":"pembrolizumab;H2RA;PPI","recist":"PR","orr":"yes","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168960"],"spots":12570430,"bases":3760098054,"biosample":"SAMN21886400","sra_experiment":"SRX12453689","sra_sample":"SRS10419729","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886400","subject_id":"PD116003dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;dermatitis","age":85,"age_category":"senior","gender":"male","bmi":32.54,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":25140860,"number_bases":3760098054,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"nivolumab;antacids;PPI;psychotropics","recist":"CR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168977"],"spots":26276137,"bases":7847411748,"biosample":"SAMN21886385","sra_experiment":"SRX12453672","sra_sample":"SRS10419712","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886385","subject_id":"PD116013dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;dermatitis","age":84,"age_category":"senior","gender":"male","bmi":23.08,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":52552274,"number_bases":7847411748,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168943"],"spots":43116123,"bases":12898222590,"biosample":"SAMN21886416","sra_experiment":"SRX12453706","sra_sample":"SRS10419746","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886416","subject_id":"PD1SS17004dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;dermatitis","age":78,"age_category":"senior","gender":"male","bmi":39.0,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":86232246,"number_bases":12898222590,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-b","treatment":"pembrolizumab;antacids;PPI;H2RA;peg-IFN;psychotropics","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168925"],"spots":21969445,"bases":6547259065,"biosample":"SAMN21886432","sra_experiment":"SRX12453724","sra_sample":"SRS10419765","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886432","subject_id":"PD125Pittsdna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;dermatitis","age":78,"age_category":"senior","gender":"male","bmi":33.47,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":43938890,"number_bases":6547259065,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab;peg-IFN","recist":"SD","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168979"],"spots":2721046,"bases":813626648,"biosample":"SAMN21886383","sra_experiment":"SRX12453670","sra_sample":"SRS10419710","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886383","subject_id":"PD117059dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;dermatitis;arthritis;colitis","age":66,"age_category":"senior","gender":"female","bmi":28.98,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":5442092,"number_bases":813626648,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab;psychotropics","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168963"],"spots":19505220,"bases":5836237260,"biosample":"SAMN21886397","sra_experiment":"SRX12453686","sra_sample":"SRS10419726","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886397","subject_id":"PD127Pittsdna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;dermatitis;neuropathy","age":74,"age_category":"senior","gender":"male","bmi":27.7,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":39010440,"number_bases":5836237260,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab;antacids;PPI;H2RA;peg-IFN;psychotropics","recist":"SD","orr":"yes","pfs12":"yes","previous_therapy":"yes","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168959"],"spots":43910447,"bases":13141481600,"biosample":"SAMN21886401","sra_experiment":"SRX12453690","sra_sample":"SRS10419730","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886401","subject_id":"PD1SS17085dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;diabetes;nephritis","age":73,"age_category":"senior","gender":"male","bmi":27.5,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":87820894,"number_bases":13141481600,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab","recist":"PR","orr":"yes","pfs12":"no","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168908"],"spots":38584602,"bases":11491191268,"biosample":"SAMN21886447","sra_experiment":"SRX12453741","sra_sample":"SRS10419781","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886447","subject_id":"PD1TPF18194dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hepatitis","age":58,"age_category":"adult","gender":"female","bmi":19.7,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":77169204,"number_bases":11491191268,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"nivolumab","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168986"],"spots":31785318,"bases":9467937360,"biosample":"SAMN21886368","sra_experiment":"SRX12453663","sra_sample":"SRS10419703","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886368","subject_id":"PD117Pittsdna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hepatitis","age":81,"age_category":"senior","gender":"female","bmi":22.79,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":63570636,"number_bases":9467937360,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab;antacids;H2RA;PPI;peg-IFN","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168966"],"spots":27735458,"bases":8290911519,"biosample":"SAMN21886395","sra_experiment":"SRX12453683","sra_sample":"SRS10419723","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886395","subject_id":"PD116009dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hepatitis","age":43,"age_category":"adult","gender":"female","bmi":41.22,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":55470916,"number_bases":8290911519,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab;H2RA;PPI;psychotropics","recist":"SD","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168914"],"spots":58067140,"bases":17321328373,"biosample":"SAMN21886442","sra_experiment":"SRX12453735","sra_sample":"SRS10419775","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886442","subject_id":"PD1TPF1830dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hypothyroidism","age":88,"age_category":"senior","gender":"male","bmi":33.75,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":116134280,"number_bases":17321328373,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab","recist":"SD","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168932"],"spots":41024060,"bases":12259632873,"biosample":"SAMN21886426","sra_experiment":"SRX12453717","sra_sample":"SRS10419757","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886426","subject_id":"PD1TPF17193dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hypothyroidism","age":74,"age_category":"senior","gender":"female","bmi":34.37,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":82048120,"number_bases":12259632873,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-b","treatment":"pembrolizumab","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"yes","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168938"],"spots":31304919,"bases":9356566057,"biosample":"SAMN21886420","sra_experiment":"SRX12453711","sra_sample":"SRS10419751","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886420","subject_id":"PD117026dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hypothyroidism","age":70,"age_category":"senior","gender":"male","bmi":32.14,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":62609838,"number_bases":9356566057,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168944"],"spots":37572235,"bases":11237460911,"biosample":"SAMN21886415","sra_experiment":"SRX12453705","sra_sample":"SRS10419745","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886415","subject_id":"PD1TPF17160dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hypothyroidism","age":83,"age_category":"senior","gender":"male","bmi":40.49,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":75144470,"number_bases":11237460911,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-b","treatment":"pembrolizumab","recist":"CR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168953"],"spots":33197900,"bases":9896135581,"biosample":"SAMN21886371","sra_experiment":"SRX12453696","sra_sample":"SRS10419736","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886371","subject_id":"PD1SS17022dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hypothyroidism","age":66,"age_category":"senior","gender":"female","bmi":24.98,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":66395800,"number_bases":9896135581,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab","recist":"CR","orr":"yes","pfs12":"yes","previous_therapy":"yes","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168930"],"spots":40073645,"bases":11942549361,"biosample":"SAMN21886427","sra_experiment":"SRX12453719","sra_sample":"SRS10419759","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886427","subject_id":"PD1SS17019dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hypothyroidism","age":84,"age_category":"senior","gender":"male","bmi":33.98,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":80147290,"number_bases":11942549361,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab;antacids;PPI;H2RA","recist":"SD","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168968"],"spots":18449063,"bases":5509873757,"biosample":"SAMN21886393","sra_experiment":"SRX12453681","sra_sample":"SRS10419721","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886393","subject_id":"PD129Pittsdna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hypothyroidism","age":83,"age_category":"senior","gender":"female","bmi":25.96,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":36898126,"number_bases":5509873757,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab;antacids;PPI;H2RA;peg-IFN","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"yes","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168937"],"spots":20228024,"bases":6052691565,"biosample":"SAMN21886421","sra_experiment":"SRX12453712","sra_sample":"SRS10419753","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886421","subject_id":"PD119Pittsdna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"yes","study_condition":"melanoma","disease":"melanoma;hypothyroidism","age":72,"age_category":"senior","gender":"male","bmi":26.62,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":40456048,"number_bases":6052691565,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-b","treatment":"pembrolizumab;peg-IFN","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168942"],"spots":45173525,"bases":13485218280,"biosample":"SAMN21886372","sra_experiment":"SRX12453707","sra_sample":"SRS10419747","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886372","subject_id":"PD118Pittsdna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hypothyroidism","age":65,"age_category":"adult","gender":"female","bmi":39.79,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":90347050,"number_bases":13485218280,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-b","treatment":"pembrolizumab;peg-IFN","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168948"],"spots":28726353,"bases":8571653890,"biosample":"SAMN21886411","sra_experiment":"SRX12453701","sra_sample":"SRS10419741","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886411","subject_id":"PD1SS17087dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hypothyroidism","age":53,"age_category":"adult","gender":"female","bmi":41.54,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":57452706,"number_bases":8571653890,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-d","treatment":"pembrolizumab;psychotropics","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168952"],"spots":45129377,"bases":13455451990,"biosample":"SAMN21886407","sra_experiment":"SRX12453697","sra_sample":"SRS10419737","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886407","subject_id":"PD1TPF17182dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hypothyroidism","age":56,"age_category":"adult","gender":"female","bmi":37.19,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":90258754,"number_bases":13455451990,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab;psychotropics","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168955"],"spots":20945266,"bases":6266261902,"biosample":"SAMN21886405","sra_experiment":"SRX12453694","sra_sample":"SRS10419734","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886405","subject_id":"PD1SS17054dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hypothyroidism","age":60,"age_category":"adult","gender":"female","bmi":38.45,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":41890532,"number_bases":6266261902,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab;psychotropics","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168980"],"spots":47872068,"bases":14262431881,"biosample":"SAMN21886382","sra_experiment":"SRX12453669","sra_sample":"SRS10419709","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886382","subject_id":"PD1SS17039dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hypothyroidism","age":75,"age_category":"senior","gender":"female","bmi":32.66,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":95744136,"number_bases":14262431881,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab;psychotropics","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"yes","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168981"],"spots":20550377,"bases":6139334907,"biosample":"SAMN21886381","sra_experiment":"SRX12453668","sra_sample":"SRS10419708","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886381","subject_id":"PD116010dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hypothyroidism","age":74,"age_category":"senior","gender":"male","bmi":27.05,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":41100754,"number_bases":6139334907,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-b","treatment":"pembrolizumab;psychotropics","recist":"SD","orr":"yes","pfs12":"yes","previous_therapy":"yes","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168910"],"spots":51781545,"bases":15448131048,"biosample":"SAMN21886446","sra_experiment":"SRX12453739","sra_sample":"SRS10419779","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886446","subject_id":"PD1TPF1847dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hypothyroidism;adrenal_insufficiency","age":90,"age_category":"senior","gender":"male","bmi":25.32,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":103563090,"number_bases":15448131048,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab","recist":"SD","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168974"],"spots":24762394,"bases":7407716711,"biosample":"SAMN21886387","sra_experiment":"SRX12453675","sra_sample":"SRS10419715","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886387","subject_id":"PD124Pittsdna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hypothyroidism;arthritis","age":56,"age_category":"adult","gender":"male","bmi":27.59,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":49524788,"number_bases":7407716711,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab;antacids;PPI;H2RA;peg-IFN;psychotropics","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168975"],"spots":31590815,"bases":9436366857,"biosample":"SAMN21886369","sra_experiment":"SRX12453674","sra_sample":"SRS10419714","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886369","subject_id":"PD1SS17005dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hypothyroidism;dermatitis","age":72,"age_category":"senior","gender":"female","bmi":30.12,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":63181630,"number_bases":9436366857,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-b","treatment":"pembrolizumab;peg-IFN;psychotropics","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168956"],"spots":1519010,"bases":454277126,"biosample":"SAMN21886404","sra_experiment":"SRX12453693","sra_sample":"SRS10419733","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886404","subject_id":"PD116261dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hypothyroidism;pneumonitis","age":66,"age_category":"senior","gender":"female","bmi":27.24,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":3038020,"number_bases":454277126,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"nivolumab;psychotropics","recist":"CR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168972"],"spots":18485170,"bases":5526089481,"biosample":"SAMN21886389","sra_experiment":"SRX12453677","sra_sample":"SRS10419717","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886389","subject_id":"PD116002dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;hypothyroidism;pneumonitis","age":80,"age_category":"senior","gender":"male","bmi":35.32,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":36970340,"number_bases":5526089481,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-b","treatment":"pembrolizumab","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"yes","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168936"],"spots":27551503,"bases":8237498752,"biosample":"SAMN21886422","sra_experiment":"SRX12453713","sra_sample":"SRS10419752","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886422","subject_id":"PD116012dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"yes","study_condition":"melanoma","disease":"melanoma;meningitis","age":67,"age_category":"senior","gender":"male","bmi":30.1,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":55103006,"number_bases":8237498752,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-b","treatment":"pembrolizumab;psychotropics","recist":"CR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168924"],"spots":34150020,"bases":10181294933,"biosample":"SAMN21886433","sra_experiment":"SRX12453725","sra_sample":"SRS10419764","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886433","subject_id":"PD1TPF18207dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"yes","study_condition":"melanoma","disease":"melanoma;myasthenia;neuropathy","age":62,"age_category":"adult","gender":"male","bmi":24.55,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":68300040,"number_bases":10181294933,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-d","treatment":"pembrolizumab;antacids;H2RA;PPI;psychotropics","recist":"CR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168965"],"spots":26777051,"bases":7960525846,"biosample":"SAMN21886396","sra_experiment":"SRX12453684","sra_sample":"SRS10419724","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886396","subject_id":"PD1TPF1822dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;pneumonitis","age":66,"age_category":"senior","gender":"female","bmi":36.17,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":53554102,"number_bases":7960525846,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"nivolumab","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168926"],"spots":25093504,"bases":7444217986,"biosample":"SAMN21886431","sra_experiment":"SRX12453723","sra_sample":"SRS10419763","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886431","subject_id":"PD117148dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;pneumonitis","age":64,"age_category":"adult","gender":"male","bmi":23.11,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":50187008,"number_bases":7444217986,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-d","treatment":"pembrolizumab;antacids;PPI;H2RA;psychotropics","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168909"],"spots":24767709,"bases":7395234453,"biosample":"SAMN21886375","sra_experiment":"SRX12453740","sra_sample":"SRS10419780","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886375","subject_id":"PD117006dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;psoriasis","age":65,"age_category":"adult","gender":"male","bmi":22.77,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":49535418,"number_bases":7395234453,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-b","treatment":"pembrolizumab;peg-IFN","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168906"],"spots":30143627,"bases":8984183053,"biosample":"SAMN21886449","sra_experiment":"SRX12453743","sra_sample":"SRS10419782","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886449","subject_id":"PD1TPF18242dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;vitiligo","age":76,"age_category":"senior","gender":"male","bmi":32.56,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":60287254,"number_bases":8984183053,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"nivolumab","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168898"],"spots":45410404,"bases":13582142739,"biosample":"SAMN21886376","sra_experiment":"SRX12453751","sra_sample":"SRS10419791","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886376","subject_id":"PD1TPF17188dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;vitiligo","age":74,"age_category":"senior","gender":"male","bmi":26.4,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":90820808,"number_bases":13582142739,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-b","treatment":"pembrolizumab","recist":"CR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168985"],"spots":26614430,"bases":7959828030,"biosample":"SAMN21886377","sra_experiment":"SRX12453664","sra_sample":"SRS10419704","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886377","subject_id":"PD117001dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;vitiligo","age":61,"age_category":"adult","gender":"male","bmi":30.36,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":53228860,"number_bases":7959828030,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-a","treatment":"pembrolizumab;peg-IFN","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
{"ncbi_accession":["SRR16168916"],"spots":54506714,"bases":16251778260,"biosample":"SAMN21886440","sra_experiment":"SRX12453733","sra_sample":"SRS10419773","sra_study":"SRP339782","study_name":"McCullochJA_2022","sample_id":"SAMN21886440","subject_id":"PD1TPF18104dna201907","country":"USA","location":"Pittsburgh","body_site":"stool","antibiotics_current_use":"no","study_condition":"melanoma","disease":"melanoma;VKH_uveitis","age":74,"age_category":"senior","gender":"male","bmi":29.7,"non_westernized":"no","days_from_first_collection":0,"sequencing_platform":"IlluminaNovaSeq","dna_extraction_kit":"PowerSoil","pmid":35228752,"number_reads":109013428,"number_bases":16251778260,"minimum_read_length":36,"median_read_length":151,"ajcc":"iv-c","treatment":"pembrolizumab;peg-IFN","recist":"PR","orr":"yes","pfs12":"yes","previous_therapy":"no","curator":"Andrea_Zen;Paolo_Manghi"}
